Where is DigPath located?

DigPath is headquartered in Palo Alto, United States.

Who is the current CEO of DigPath?

Webster Lincoln of DigPath. They have also founded 1 company.

How many employees does DigPath have?

As of Apr 30, 2026, the latest employee count at DigPath is 11.

Is DigPath a funded company?

DigPath is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does DigPath rank among its competitors?

DigPath ranks 253rd amongst 1019 active competitors, of which 243 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Qure.ai, which secured an undisclosed amount in Jan, 2026.

Who are the top competitors of DigPath?

DigPath's top competitors include AIdoc, PathAI and Perspectum. Among them, Qure.ai secured the most recent funding round in January, 2026.

DigPath - 2026 Company Profile, Team & Competitors

Company Details

AI-driven digital pathology company for diagnostics and research. The company is developing a robust AI system capable of performing comprehensive analyses on whole slide pathology images.

Key Metrics

Founded Year

2023

Location

Palo Alto, United States

Stage

Unfunded

Ranked

253^rd among 1019 active competitors

Employee Count

11 as on Apr 30, 2026

Similar Companies

PathAI & 865 more

View DigPath's full profile

DigPath has not raised any funding rounds yet.

The founders of DigPath are Inema Orukari and Webster Lincoln. Webster Lincoln is the CEO of DigPath.

Here are the details of DigPath's key team members:

Inema Orukari: Co-Founder of DigPath.
Contact Info: 1 email address
Webster Lincoln: Co-Founder & CEO of DigPath.
Contact Info: 1 email address

View details of DigPath's Founder profiles and Board Members

DigPath's employee count trend

DigPath has 11 employees as of Apr 26. Here is DigPath's employee count trend over the years:

Uncover DigPath's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of DigPath include AIdoc, PathAI and Perspectum. Here is the list of Top 10 competitors of DigPath, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	AIdoc 2016, New York City (United States), Series E	Developer of clinical AI solutions for healthcare imaging and patient management	$384M	AIC, General Catalyst & 33 others	71/100
2nd	PathAI 2016, Boston (United States), Series C	Provider of digital pathology image management system for clinical labs	$255M	General Catalyst, Kaiser Permanente & 21 others	70/100
3rd	Perspectum 2012, Oxford (United Kingdom), Series C	Provider of precision medicine software for the diagnosis of liver diseases	$140M	Oppenheimer, Health Quest Capital & 30 others	70/100
4th	Qure.ai 2016, Mumbai (India), Series D	Provider of AI-powered solutions for medical image analysis and reporting	$123M	Merck, 360 One & 46 others	69/100
5th	Subtle Medical 2017, Palo Alto (United States), Series B	AI-driven solutions for medical diagnostic imaging	$50M	3E Bioventures Capital, Bessemer Venture Partners ... & 23 others	66/100
6th	Aignostics 2018, Berlin (Germany), Series B	Provider of AI-driven solutions for drug development and precision medicine	$53.9M	Boehringer Ingelheim Venture Fund, Wellington Partners Venture Capital ... & 9 others	66/100
7th	PAIGE 2018, New York City (United States), Acquired	Developer of AI applications and foundation models for cancer diagnostics	$241M	Casdin Capital, Goldman Sachs & 9 others	65/100
8th	Vista 2012, Palo Alto (United States), Series B	AI-guided software for clinicians to automate MRI exams	$38.2M	Khosla Ventures, Open Field Capital & 12 others	64/100
9th	IXICO 2004, London (United Kingdom), Public	AI-based medical image management and analysis solutions for healthcare organizations	-	Leonne International, Gov.uk & 3 others	64/100
10th	Cleerly 2016, Denver (United States), Series C	Provider of an AI-driven platform for coronary artery disease assessment	$578M	T. Rowe Price, Fidelity Investments & 20 others	63/100
253rd	DigPath 2023, Palo Alto (United States), Unfunded	AI-driven digital pathology company for diagnostics and research	-	-	35/100